autoimmune conference-coverage

Conference Coverage

Paras Karmacharya, MD, on Identifying Distinct Phenotypes in PsA

11/15/2023

Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.

Dr Paras Karmacharya discusses...

11/15/2023

Autoimmune

Conference Coverage

Impact of Social Determinants of Health on Chronic Conditions

11/13/2023

Priyam Vora, Associate Editor

Research presented at ACR Convergence assessed the impact of social determinants of health on patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.

Research presented at ACR...

11/13/2023

Rheumatology & Arthritis

Conference Coverage

Discrepancies Between Patients' and Physicians' Global Assessments in PsA

11/13/2023

Priyam Vora, Associate Editor

Dr Proton Rahman identified factors driving disagreement between patients and physicians analyzing the data from more than 1000 participants.

Dr Proton Rahman identified...

11/13/2023

Rheumatology & Arthritis

Conference Coverage

Clinical-Genetic Risk Score Developed for ILD Among Patients With RA

11/12/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...

A new combined clinical-genetic risk score has demonstrated superiority to clinical risk factors alone for diagnosing interstitial lung disease (ILD) among patients with rheumatoid arthritis (RA).

A new combined clinical-genetic...

11/12/2023

Rheumatology & Arthritis

Conference Coverage

Patient-Reported Outcomes in RA: Shilpa Venkatachalam, PhD

11/12/2023

Priyam Vora, Associate Editor

Can digital health tools offer more insight outside of clinical setting in the treatment of rheumatoid arthritis? Dr Shilpa Venkatachalam spoke on the topic at ACR Convergence.

Can digital health tools offer...

11/12/2023

Rheumatology & Arthritis

Conference Coverage

Joseph Merola, MD, MMSc, on the Long-Term Efficacy of Risankizumab for PsA

07/19/2023

Dr Merola and colleagues conducted a post hoc analysis of the KEEPsAkE 1 and 2 trials of risankizumab among patients with active psoriatic arthritis to evaluates patient subgroups at 52 weeks of treatment.

Dr Merola and colleagues...

07/19/2023

Rheumatology & Arthritis

Expert Insights

Joseph F. Merola, MD, MMSc, on Overcoming the Challenges in Psoriatic Arthritis Diagnosis and Treatment

06/27/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...

Tight control of psoriatic arthritis and an interdisciplinary approach are key factors in achieving low disease activity or remission, according to Dr Joseph Merola.

Tight control of psoriatic...

06/27/2023

Rheumatology & Arthritis

Conference Coverage

IMID Symptoms—Beyond the Physical

06/22/2023

Priyam Vora, Associate Editor

Immune mediated inflammatory disease symptoms are more than just physiological, extending from anxiety to depression to fatigue.

Immune mediated inflammatory...

06/22/2023

Autoimmune

Conference Coverage

Considerations in Managing Pregnancy Among Patients with IMIDs

06/21/2023

Priyam Vora, Associate Editor

Uma Mahadevan, MD, and Christopher Robinson, MD, discuss the importance of preconception counseling for a patient with immune-mediated inflammatory disease to boost their chances of achieving and maintaining a healthy pregnancy.

Uma Mahadevan, MD, and...

06/21/2023

Autoimmune

Conference Coverage

Jennifer Mandal, MD, on the Rheumatology Access Expansion Initiative

06/09/2023

Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.

Dr Mandal, from the University...

06/09/2023

Rheumatology & Arthritis

Conference Coverage

Popular Articles

Stay In the Know

Specialties

Events

Year Round Education

HMP Global Products